Founder mutation Arg485Pro led to recurrent compound heterozygous GGCX genotypes in two German patients with VKCFD type 1. [electronic resource]
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Sep 2006
- 503-7 p. digital
Publication Type: Case Reports; Journal Article
0957-5235
10.1097/01.mbc.0000240927.88177.d1 doi
Adult Carbon-Carbon Ligases--genetics Conserved Sequence--genetics Female Founder Effect Haplotypes--genetics Humans Infant Male Mixed Function Oxygenases--deficiency Sequence Analysis, DNA Vitamin K--administration & dosage Vitamin K Epoxide Reductases